Delivery Of A Reimbursed Form Of Bevacizumab 100 Mg/ 4 Ml And 400 Mg/ 16 Ml For Intravenous Use

  Address - Belgium

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 119289496

  Document Type - Tender Notices

Description - Description: Object of these deliveries: delivering a reimbursed form of Bevacizumab 100 mg/ 4 ml and 400 mg/ 16 ml for intravenous use.It is expected that the tenderer will make approximately 21 % of the estimated annual consumption available as a m edical sample annually to the requests of the doctors to administer the product outside reimbursable indications (cf. in accordance with the KB of 11 January 1993 establishing the conditions under which medicines for human use in the form of samples may be handed over).local title:: Leveren van een terugbetaalde vorm van Bevacizumab 100 mg/4 ml en 400 mg/ 16ml voor intraveneus gebruikContract Duration: : 48 DAYContract Type: : Supplylocal descrip

Mt Ref Id - 119289496

Deadline - Nov 03, 2025